| Fund Name | Location |
| Apollo Consulting SRL | - |
| Arancia International | Guadalajara, Jalisco, Mexico |
| D-Prize | California, San Francisco, United States |
| Digital Surgeons | Connecticut, New Haven, United States |
| Dongyang Hengdian Qiaobao Yingshi Wenhua Gongzuoshi | China, Dongyang, Zhejiang |
| Enable Capital Management | California, San Francisco, United States |
| Everbright | China, Hong Kong, Hong Kong Island |
| Fallon Community Health Plan | Massachusetts, United States, Worcester |
| FTIG | - |
| Futury Regio Growth Fund | Frankfurt, Germany, Hessen |
| GPS Ventures GmbH | Berlin, Berlin, Germany |
| HIGHROAD | Azor, Israel, Tel Aviv |
| Marin Investments | British Columbia, Canada, Vancouver |
| Mosaic Capital Partners | Charlotte, North Carolina, United States |
| Newlight Management | New York, New York, United States |
| Nouville Holdings | Canada, Ontario, Ottawa |
| Techstars Retail Accelerator | Minneapolis, Minnesota, United States |
| Tudor Investments | Connecticut, Greenwich, United States |
| Tune Labs | Kuala Lumpur, Malaysia |
| Warisan Investment Partners | Switzerland, Zug, Zug |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
HepaRegeniX | $12M | 21 Jan 2020 | Ulm, Baden-Württemberg, Germany | ||
OMEICOS Therapeutics | $9M | 01 Mar 2017 | Berlin, Berlin, Germany |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
HepaRegeniX | $12M | 21 Jan 2020 | Ulm, Baden-Württemberg, Germany | ||
OMEICOS Therapeutics | $9M | 01 Mar 2017 | Berlin, Berlin, Germany |
